Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Sanofi's meningococcal vax rivalry with Novartis ends in $61.5M class-action settlement
Sanofi's meningococcal vax rivalry with Novartis ends in $61.5M class-action settlement
Sanofi's meningococcal vax rivalry with Novartis ends in $61.5M class-action settlement
Submitted by
admin
on January 30, 2017 - 10:58pm
Source:
Fierce Pharma
News Tags:
Sanofi
meningococcal disease
Novartis
vaccines
Menveo
Menactra
Headline:
Sanofi's meningococcal vax rivalry with Novartis ends in $61.5M class-action settlement
Do Not Allow Advertisers to Use My Personal information
